Article

Probiotic-derived strain-specific metabolites ameliorate metabolic dysfunction-associated steatotic liver disease through modulation of the gut-liver axis

2025-07-15

Abstract excerpt

<title>Abstract</title> <p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent chronic liver condition lacking approved treatments, where the gut-liver axis is a key therapeutic target. This study aimed to identify novel probiotic strains and elucidate their strain-specific mechanisms by profiling their functional metabolites. We first investigated gut microbiota alterations in a human...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1531a16d-9afd-5c7b-82c2-617664fcb865
DOI: 10.21203/rs.3.rs-7073349/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Probiotic-derived strain-specific metabolites ameliorate metabolic dysfunction-associated steatotic liver disease through modulation of the gut-liver axisDOI 10.21203/rs.3.rs-7073349/v1Read

Exploring the Role of Probiotics, Prebiotics, and Synbiotics in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease—A Scoping ReviewSemantic proximity Read

Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and ChallengesSemantic proximity Read

Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver DiseaseSemantic proximity Read

NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment OptionsSemantic proximity Read

Gut Microbiota and Metabolite Dynamics in a MASLD-Associated Liver Fibrosis In Vivo Model: An Integrative Multi-Omic PerspectiveSemantic proximity Read

Bridging the Gut and Liver: Multi-biotics modulate microbiota composition and corroborate transcriptomic improvements in MASLDSemantic proximity Read

Gut microbiota-derived metabolites as central regulators in metabolic disordersSemantic proximity Read

Towards Individualized Use of Probiotics and Prebiotics for Metabolic Syndrome and Associated Diseases Treatment: Does Pathophysiology-Based Approach Work and Can Anticipated Evidence Be Completed?Semantic proximity Read

Integrative analysis of gut microbiota and fecal metabolites in metabolic associated fatty liver disease patientsSemantic proximity Read

Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinomaSemantic proximity Read

The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategySemantic proximity Read

The Probiotic Potential of Enterococcus faecium 140623, the Production Strain for Lactasin Tablets: Safety Assessment and Modulating Host MetabolismSemantic proximity Read